Various biological and molecular factors, including histological subtype, tumor mutational burden, and programmed death ligand 1 (PD-L1) expression, have been investigated for this purpose, but the results have been inconclusive [7,8,9,10]. The gene discussed is CD274; the disease is neoplasm.